Science Explorer Back to mapMap
Discussion
Company · Waltham · United States

Eloxx Pharmaceuticals (United States)

eloxxpharma.comROR OpenAlex
Research works
89
▲ 4% vs 2018-21
Citations
4.6k
51.4 per fractional work
Top-10% rate
18.8%
all institutions 10.0%
Open access
45%
world 40%
International
18%
world 18%
Eloxx Pharmaceuticals (United States)

Not ranked overall: Eloxx Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Eloxx Pharmaceuticals (United States) work in?

In 2022-now, 45% of research at Eloxx Pharmaceuticals (United States) is in Health Sciences, 44% in Life Sciences. Its largest fields are Medicine (44%), Biochemistry, Genetics and Molecular Biology (32%), Immunology and Microbiology (7%). It does 2.2× the world's share of Life Sciences.

Health Sciences: 10 fractional works · 44.9% of its workMedicine: 10 fractional works · 44.4% of its workPsychiatry and Mental health: 2 fractional works · 7.4% of its workPulmonary and Respiratory Medicine: 1 fractional works · 5.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 4.7% of its workImmunology and Allergy: 1 fractional works · 4.0% of its workPathology and Forensic Medicine: 1 fractional works · 3.4% of its workSurgery: 1 fractional works · 2.8% of its workOncology: 1 fractional works · 2.8% of its workHematology: 0 fractional works · 1.9% of its workEpidemiology: 0 fractional works · 1.7% of its workGenetics: 0 fractional works · 1.7% of its workRheumatology: 0 fractional works · 1.4% of its workPhysiology: 0 fractional works · 1.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.3% of its workInfectious Diseases: 0 fractional works · 1.2% of its workNeurology: 0 fractional works · 1.0% of its workPharmacology: 0 fractional works · 0.7% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.5% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.3% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.5% of its workNutrition and Dietetics: 0 fractional works · 0.5% of its workLife Sciences: 10 fractional works · 44.3% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 31.6% of its workMolecular Biology: 4 fractional works · 18.8% of its workGenetics: 1 fractional works · 6.0% of its workCell Biology: 1 fractional works · 4.8% of its workBiotechnology: 0 fractional works · 1.1% of its workCancer Research: 0 fractional works · 0.5% of its workBiochemistry: 0 fractional works · 0.3% of its workImmunology and Microbiology: 2 fractional works · 6.8% of its workImmunology: 1 fractional works · 5.5% of its workVirology: 0 fractional works · 1.1% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.2% of its workNeuroscience: 1 fractional works · 5.6% of its workCellular and Molecular Neuroscience: 1 fractional works · 4.5% of its workCognitive Neuroscience: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.3% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.3% of its workPhysical Sciences: 1 fractional works · 5.9% of its workChemistry: 1 fractional works · 4.8% of its workOrganic Chemistry: 1 fractional works · 4.8% of its workMaterials Science: 0 fractional works · 0.7% of its workBiomaterials: 0 fractional works · 0.7% of its workMathematics: 0 fractional works · 0.3% of its workStatistics and Probability: 0 fractional works · 0.3% of its workEngineering: 0 fractional works · 0.0% of its workSocial Sciences: 1 fractional works · 4.9% of its workDecision Sciences: 1 fractional works · 2.2% of its workManagement Science and Operations Research: 0 fractional works · 2.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.7% of its workEconomics and Econometrics: 0 fractional works · 1.7% of its workPsychology: 0 fractional works · 1.0% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.5% of its workSocial Psychology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workALL ITS WORKEloxxPharmaceuticals…23fractional works, 2022-now
Life Sciences44%Physical Sciences6%Health Sciences45%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Medicine1044.4%
    2. Nursing00.5%
    1. Biochemistry, Genetics and Molecular Biology731.6%
    2. Immunology and Microbiology26.8%
    3. Neuroscience15.6%
    4. Agricultural and Biological Sciences00.3%
    1. Chemistry14.8%
    2. Materials Science00.7%
    3. Mathematics00.3%
    4. Engineering00.0%
    1. Decision Sciences12.2%
    2. Economics, Econometrics and Finance01.7%
    3. Psychology01.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.05× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.92× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 6.78× its world share, 2 worksImmunology and Micro…Neuroscience: 3.47× its world share, 1 worksNeuroscienceChemistry: 3.08× its world share, 1 worksChemistryMaterials Science: 0.21× its world share, 0 worksMaterials ScienceMathematics: 0.21× its world share, 0 worksMathematicsMedicine: 2.31× its world share, 10 worksMedicineNursing: 0.99× its world share, 0 worksNursingDecision Sciences: 2.28× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.81× its world share, 0 worksEconomics, Econometr…Psychology: 0.33× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.8×. Every wedge is a field page.

All 12 fields, with their numbers
  1. Immunology and Microbiology6.78×2 works
  2. Biochemistry, Genetics and Molecular Biology5.92×7 works
  3. Neuroscience3.47×1 works
  4. Chemistry3.08×1 works
  5. Medicine2.31×10 works
  6. Decision Sciences2.28×0 works
  7. Nursing0.99×0 works
  8. Economics, Econometrics and Finance0.81×0 works
  9. Psychology0.33×0 works
  10. Materials Science0.21×0 works
  11. Mathematics0.21×0 works
  12. Agricultural and Biological Sciences0.05×0 works

Who are the top researchers at Eloxx Pharmaceuticals (United States)?

Ranked on the quality score, Matthew M. Goddeeris, Maureen A. Dillon and Jean Engels lead among researchers whose main affiliation is Eloxx Pharmaceuticals (United States).

  1. 1 Matthew M. Goddeeris United States · #422,321 worldwide 1.4k citations · 29 works
  2. 2 Maureen A. Dillon United States · #626,359 worldwide 3.3k citations · 18 works
  3. 3 Jean Engels United States · #1,543,806 worldwide 319 citations · 15 works
  4. 4 W. Harry Mandeville United States · #2,973,692 worldwide 555 citations · 20 works
  5. 5 Vasudeo Badarinarayana United States · #3,721,067 worldwide 851 citations · 67 works
All ranked researchers at Eloxx Pharmaceuticals (United States)

What are the most cited papers from Eloxx Pharmaceuticals (United States)?

The most cited paper from Eloxx Pharmaceuticals (United States) is "Cardiac calcification in adult hemodialysis patients" (Paolo Raggi, Amy Boulay, Scott Chasan-Taber et al., 2002), with 1,130 citations. Next come "Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663" (329) and "RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone" (304).

Most cited papers
#PaperReleasedCitations
1 Cardiac calcification in adult hemodialysis patients Paolo Raggi, Amy Boulay, Scott Chasan-Taber et al. · Journal of the American College of Cardiology Open access Feb 2002 1,130
2 Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663 Margaret van Heek, Constance Farley, Douglas S. Compton et al. · British Journal of Pharmacology Open access Apr 2000 329
3 RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone Eduardo A. Slatopolsky, Steven K. Burke, Maureen A. Dillon · Kidney International Open access 1999 304
4 Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation Driss El Kebir, Per Gjorstrup, János G. Filep · Proceedings of the National Academy of Sciences Open access 27 Aug 2012 285
5 A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients Anthony J. Bleyer, Steven K. Burke, Maureen A. Dillon et al. · American Journal of Kidney Diseases Apr 1999 277
All 61 most cited papers, with filters and sorting

Which keywords describe research at Eloxx Pharmaceuticals (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer, Inflammation, Cell Adhesion, Drug Discovery, Neurobiology, Treatment, Angiogenesis and Chronic Fatigue Syndrome.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 12 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 12 words, with their numbers
  1. Inflammation3▲ 5.3×11 topics
  2. Cancer2▲ 7.8×7 topics
  3. Epidemiology2▲ 2.6×12 topics
  4. Cell Adhesion2▲ 183×3 topics
  5. Drug Discovery2▲ 33×3 topics
  6. Neurobiology2▲ 28×3 topics
  7. Treatment2▲ 6.2×3 topics
  8. Angiogenesis2▲ 19×5 topics
  9. Chronic Fatigue Syndrome1▲ 228×1 topic
  10. Fibromyalgia1▲ 228×1 topic
  11. Extracellular Matrix1▲ 31×3 topics
  12. Glycosylation1▲ 40×2 topics

Which research topics does Eloxx Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Fibromyalgia and Chronic Fatigue Syndrome Research, Cell Adhesion Molecules Research, Skin and Cellular Biology Research and Monoclonal and Polyclonal Antibodies Research.

Fibromyalgia and Chronic Fatigue Syndrome Research: 1 fractional worksCell Adhesion Molecules Research: 1 fractional worksSkin and Cellular Biology Research: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksClick Chemistry and Applications: 1 fractional worksChemical Synthesis and Analysis: 1 fractional worksNeurotransmitter Recepto…1Neurotransmitter Receptor Influence on Behavior: 1 fractional worksImpact of AI and Big Data on Business and Society: 0 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 0 fractional worksRespiratory and Cough-Related Research: 0 fractional works
Psychiatry and Mental healthImmunology and AllergyCell BiologyRadiology, Nuclear Medicine and Imaging6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Fibromyalgia and Chronic Fatigue Syndrome Research Psychiatry and Mental health 1 works
  2. 2 Cell Adhesion Molecules Research Immunology and Allergy 1 works
  3. 3 Skin and Cellular Biology Research Cell Biology 1 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  5. 5 Click Chemistry and Applications Organic Chemistry 1 works
  6. 6 Chemical Synthesis and Analysis Molecular Biology 1 works
  7. 7 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 1 works
  8. 8 Impact of AI and Big Data on Business and Society Management Science and Operations Research 0 works
  9. 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  10. 10 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.3%not open54.7%

World: 40% of research is openly available.

with international co-authors18.4%domestic only81.6%

World: 18% is written across borders.

How has Eloxx Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 4% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Eloxx Pharmaceuticals (United States) as a percentage of every work published that year, 0.000097% in 2024.

still counting0.00020%0.00040%0.00060%Eloxx Pharmaceuticals (United States)0.00012% in 20251990200020102020

Fractional works of Eloxx Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Waltham

All research institutions in Waltham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Eloxx Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.